AR025610A1 - Derivados de triazol que tienen actividad antifungal - Google Patents

Derivados de triazol que tienen actividad antifungal

Info

Publication number
AR025610A1
AR025610A1 ARP000104723A ARP000104723A AR025610A1 AR 025610 A1 AR025610 A1 AR 025610A1 AR P000104723 A ARP000104723 A AR P000104723A AR P000104723 A ARP000104723 A AR P000104723A AR 025610 A1 AR025610 A1 AR 025610A1
Authority
AR
Argentina
Prior art keywords
antifungal activity
triazol derivatives
triazol
derivatives
group
Prior art date
Application number
ARP000104723A
Other languages
English (en)
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of AR025610A1 publication Critical patent/AR025610A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/56—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and doubly-bound oxygen atoms bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Los compuestos de la siguiente formula (1) y sus sales y ésteres, farmacéuticamente aceptables de la formula (1) en la que Ar es un grupo fenilo que puedeestar sustituido opcionalmente con 1 a 3 sustituyentes, seleccionados del grupo que consiste deátomos de halogeno y grupos de trifluorometilo, tienenexcelente actividad antifungal.
ARP000104723A 1999-09-09 2000-09-08 Derivados de triazol que tienen actividad antifungal AR025610A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP25570299 1999-09-09
JP2000103826 2000-04-05

Publications (1)

Publication Number Publication Date
AR025610A1 true AR025610A1 (es) 2002-12-04

Family

ID=26542380

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000104723A AR025610A1 (es) 1999-09-09 2000-09-08 Derivados de triazol que tienen actividad antifungal

Country Status (23)

Country Link
US (3) US6391903B1 (es)
EP (1) EP1083175B1 (es)
KR (1) KR100592201B1 (es)
CN (1) CN1167700C (es)
AR (1) AR025610A1 (es)
AT (1) ATE244238T1 (es)
AU (1) AU778073B2 (es)
BR (1) BR0004066A (es)
CA (1) CA2317691C (es)
DE (1) DE60003618T2 (es)
DK (1) DK1083175T3 (es)
ES (1) ES2200786T3 (es)
HK (1) HK1034259A1 (es)
HU (1) HU224699B1 (es)
ID (1) ID27234A (es)
IL (1) IL138329A0 (es)
NO (1) NO318352B1 (es)
NZ (1) NZ506818A (es)
PT (1) PT1083175E (es)
RU (1) RU2203280C2 (es)
SA (1) SA00210602B1 (es)
TR (1) TR200002610A3 (es)
TW (1) TW530057B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI334866B (en) 2002-05-29 2010-12-21 Mercian Corp Novel physiologically active substances
WO2004108134A1 (ja) * 2003-06-06 2004-12-16 Sankyo Company, Limited トリアゾール化合物を含有する医薬組成物
KR101191682B1 (ko) * 2005-12-01 2012-10-16 바실리어 파마슈티카 아게 에폭시부탄올 중간체의 제조 방법
EP2116542A4 (en) 2007-01-29 2011-05-04 Eisai R&D Man Co Ltd SOLID OF A MAKROLIDE COMPOUND, METHOD OF MANUFACTURING THEREOF AND PHARMACEUTICAL COMPOSITION THEREWITH

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8322983D0 (en) * 1983-08-26 1983-09-28 Pfizer Ltd Triazole antifungal agents
US4483863A (en) * 1984-01-20 1984-11-20 Pfizer Inc. Triazole antifungal agents
GB9002375D0 (en) * 1990-02-02 1990-04-04 Pfizer Ltd Triazole antifungal agents
CA2049802A1 (en) * 1990-08-26 1992-02-27 Sadao Oida Anti-fungal triazole derivatives, their preparation and uses
HU227320B1 (en) 1995-04-06 2011-03-28 Daiichi Sankyo Co Ltd 1,2,4-triazole-derivatives, fungicide compositions containing these compounds as active ingredients
JP2902345B2 (ja) 1995-04-06 1999-06-07 三共株式会社 トリアゾール抗真菌剤
EP0780380B1 (en) * 1995-12-22 2001-06-13 Ss Pharmaceutical Co., Ltd. Triazole derivatives with antimycotic action and intermediates
JP3622882B2 (ja) 1996-10-04 2005-02-23 三共株式会社 トリアゾール誘導体を含有する医薬
AU5779598A (en) 1997-02-04 1998-08-25 Sankyo Company Limited Triazole derivatives
AU7937998A (en) 1997-07-08 1999-02-08 Sankyo Company Limited Antifungal triazole compounds
US6303728B1 (en) 1997-07-08 2001-10-16 Kaneka Corporation Hydrosilylation process and polymers produced by the process
JPH1180135A (ja) 1997-07-08 1999-03-26 Sankyo Co Ltd 抗真菌トリアゾール化合物

Also Published As

Publication number Publication date
TR200002610A2 (tr) 2001-06-21
AU5657500A (en) 2001-03-15
US6392082B1 (en) 2002-05-21
CN1291610A (zh) 2001-04-18
IL138329A0 (en) 2001-10-31
EP1083175A2 (en) 2001-03-14
NZ506818A (en) 2001-07-27
NO20004511L (no) 2001-03-12
US6337403B1 (en) 2002-01-08
HUP0003555A2 (hu) 2002-05-29
TR200002610A3 (tr) 2001-06-21
EP1083175A3 (en) 2001-04-11
BR0004066A (pt) 2001-04-17
ID27234A (id) 2001-03-15
CA2317691C (en) 2009-02-17
DK1083175T3 (da) 2003-10-06
CA2317691A1 (en) 2001-03-09
AU778073B2 (en) 2004-11-11
RU2203280C2 (ru) 2003-04-27
PT1083175E (pt) 2003-09-30
KR20010067169A (ko) 2001-07-12
TW530057B (en) 2003-05-01
HU0003555D0 (en) 2000-09-08
DE60003618D1 (de) 2003-08-07
CN1167700C (zh) 2004-09-22
US6391903B1 (en) 2002-05-21
SA00210602B1 (ar) 2006-06-04
HK1034259A1 (en) 2001-10-19
KR100592201B1 (ko) 2006-06-23
ATE244238T1 (de) 2003-07-15
HU224699B1 (en) 2006-01-30
NO20004511D0 (no) 2000-09-08
DE60003618T2 (de) 2004-04-15
NO318352B1 (no) 2005-03-07
EP1083175B1 (en) 2003-07-02
ES2200786T3 (es) 2004-03-16

Similar Documents

Publication Publication Date Title
CR6682A (es) Inhibidores no peptidicos de la union celular dependiente de vla-4 utiles en el tratamiento de enfermedades inflamatorios, autoinmunes y respiratorias
SE0202463D0 (sv) Novel compounds
ATE334961T1 (de) Herbizide
TR200201505T2 (tr) Terapötik maddeler olarak pirazolopirimidinler
AR029766A1 (es) Compuesto inhibidor de quinasa y uso del mismo para preparar una composicion farmaceutica
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
CO4900063A1 (es) Piridinas substituidas como inhibidores selectivos de ciclo- oxi-genasa2
HRP20010573B1 (en) Tricyclic inhibitors of poly(adp-ribose) polymerases
MY137156A (en) Dual nk1/nk3 derivatives
TR200001690T2 (tr) Triazin damar gelişimi önleyicileri
NO972615D0 (no) Benzimidazolderivater
DOP2009000106A (es) Compuestos de pirazol y triazol sustituídos como inhibidores de ksp
RS50229B (sr) Analozi vitamina d3
DK1313740T3 (da) Prodrugs af imidazopyridinderivater
DE60112960D1 (de) Kondensierte pyridoindolderivate
AR025610A1 (es) Derivados de triazol que tienen actividad antifungal
RS50002B (sr) Eletriptan hidrobromid monohidrat
ES2178765T3 (es) Nuevos derivados de 1,7,7-trimetil-biciclo (2.2.1) heptano.
EE200300129A (et) Distamütsiini alfa-halogenoakrüloüülderivaadi kasutamine
DE69103968D1 (de) 2-(Aminoalkyl)-5-(arylalkyl)1,3-dioxanderivate, ihre Herstellung und ihre Anwendung in der Therapeutik.
NO911459D0 (no) Anvendelse av metallion-komplekser som belegginhibitorer.
MXPA02004441A (es) Derivados de isoxazol como inhibidores de la fosfodiesterasa.
NO890440L (no) Fremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater.
ATE360423T1 (de) Verwendung von chymase hemmern gegen vaskuläre lipidablagerung
ES2036137B1 (es) Procedimiento para la preparacion de la nueva 1-(3-clorofenil)-4-hidroximetil-7,8-dimetoxi-5h-2,3-benzodiacepina y de sus sales de adicion acida.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal
FB Suspension of granting procedure